Evaluation of two traditional Chinese medicine formulations for the treatment of the metabolic syndrome regarding cardiovascular function and insulin sensitivity

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-09000651

Enrollment

Unknown

Registered

2005-09-09

Start date

2001-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gland and Hormone Related Diseases

Interventions

two groups:Three Essence Capsule 12 weeks versus placebo

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes

Exclusion criteria

Exclusion criteria: uncontrolled condition requiring treatment modification

Design outcomes

Primary

Measure	Time frame
Changes in fasting and 2hr plasma glucose when challenged by a oral glucose tolerance test;	—

Secondary

Measure	Time frame
Cardiovascular function measured by impedance and psychomotor function;	—

Countries

China

Contacts

Public ContactBrian Tomlinson

www.na@163.com+852 26323139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026